Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IJR vs GSK✓SelectedUSD · GSKIJR vs GSK performance historyLatest closeAs of-1.22%11/16
Stock and ETF performance explorer

IJR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,106.9%
GSK return
+192.5%
Excess return
+914.4%
Maximum drawdown
-58.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.2%-0.1%-1.1%-1.2%
7D-2.0%-1.3%-0.7%-1.5%
30D+2.2%+2.7%-0.5%+1.0%
3M-7.3%+2.7%-10.1%-8.7%
6M+4.4%+3.3%+1.1%+2.1%
YTD+16.5%+6.5%+10.1%+11.9%
1Y+20.4%+10.7%+9.7%+13.7%
3Y+52.9%+64.4%-11.4%+17.7%
5Y+25.4%+46.7%-21.3%-0.7%
10Y+146.4%+109.4%+37.1%+62.4%
All+1,106.9%+192.5%+914.4%+516.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling